A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression

被引:21
|
作者
Mazeh, Doron
Shahal, Baruch
Aviv, Alex
Zemishlani, Hanna
Barak, Yoram
机构
[1] Y Abarbanel Mental Hlth Ctr, Psychogeriatr Ward A, IL-59100 Bat Yam, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
关键词
elderly; paroxetine; resistant depression; venlafaxine;
D O I
10.1097/YIC.0b013e32817396ae
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It is estimated that up to 45% of patients with depression do not have an adequate response to a first trial of antidepressant therapy with even higher reported rates for the elderly patients. To compare the efficacy and the tolerability of venlafaxine vs. paroxetine in elderly patients suffering from resistant major depression, who did not respond to at least two previous adequate trials of antidepressants. Patients entered an 8-week single-blind study. Patients were rated using the Clinical Global Impression Scale, Hamilton Rating Scale for Depression, and the Geriatric Depression Scale. Assessments were performed at baseline and on days 7, 14, 21, 28, 42 and 56. Side effects were recorded in a systemic manner. Thirty patients were included in the study, (17 women, 13 men; mean age=75.9 years, range: 68-83) and all had completed the 6-week trial. Mean dose of venlafaxine used was 165 mg/day (SD=73.8; range 75-300 mg). Mean dose of paroxetine used was 26 mg/day (SD=15.04; range 10-60 mg). Nine patients treated with venlafaxine (60%) and five patients treated with paroxetine (33%) remitted after 8 weeks of treatment. Four patients treated with venlafaxine and eight patients treated with paroxetine failed to respond. Significant improvement in Hamilton Rating Scale for Depression scores between baseline and endpoint were observed in both groups of patients. The mean Hamilton Rating Scale for Depression change for paroxetine was -12.5 and for venlafaxine -19.1 (P < 0.05). The mean Geriatric Depression Scale change for paroxetine was -3.2 and for venlafaxine -6.0 (P < 0.3). The mean Clinical Global Impression Scale change was -2.3 for paroxetine and -3.5 for venlafaxine (P < 0.05). Venlafaxine was significantly superior to paroxetine on Clinical Global Impression Scale and Hamilton Rating Scale for Depression measures. Side effects were transient and did not differ between treatment groups. Elderly depressed patients resistant to previous treatments had responded to a trial of paroxetine or venlafaxine. Remission rates were higher for venlafaxine and tolerability was acceptable for both compounds.
引用
收藏
页码:371 / 375
页数:5
相关论文
共 50 条
  • [31] Comparisons of the Efficacy and Tolerability of Extended-Release Venlafaxine, Mirtazapine, and Paroxetine in Treatment-Resistant Depression A Double-Blind, Randomized Pilot Study in a Chinese Population
    Fang, Yiru
    Yuan, Chengmei
    Xu, Yifeng
    Chen, Jun
    Wu, Zhiguo
    Cao, Lan
    Yi, Zhenghui
    Hong, Wu
    Wang, Yong
    Jiang, Kaida
    Gao, Keming
    Cui, Xingjia
    Nierenberg, Andrew A.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (04) : 357 - 364
  • [32] IMPACT OF VALPROATE AND PHENYTOIN ON COGNITIVE FUNCTION IN ELDERLY PATIENTS - RESULTS OF A SINGLE-BLIND RANDOMIZED COMPARATIVE-STUDY
    CRAIG, I
    TALLIS, R
    EPILEPSIA, 1994, 35 (02) : 381 - 390
  • [33] A Multi-Center, Single-Blind, Randomized Controlled Trial of Ciprofol and Propofol During Gastroscopy in Elderly Patients
    Zhang, Xiang
    Zhu, Tao
    ANESTHESIA AND ANALGESIA, 2024, 139 (06): : 1883 - 1884
  • [34] A randomized single-blind study of sertraline vs. amitriptiline for the treatment of depression in patients with Parkinson's disease
    Antonini, A
    Tesei, S
    Zecchinelli, A
    Sacilotto, G
    Meucci, N
    Canesi, M
    Pezzoli, G
    NEUROLOGY, 2005, 64 (06) : A108 - A108
  • [35] A randomized single-blind study of sertraline vs. amitriptiline for the treatment of depression in patients with Parkinson's disease
    Antonini, A
    Zecchinelli, A
    Tesei, S
    Sacilotto, G
    Meucci, N
    Pezzoli, G
    MOVEMENT DISORDERS, 2004, 19 : S263 - S263
  • [36] The Effect of a Foot Bath on Sleep Quality in the Elderly: A Single-Blind Randomized Controlled Trial
    Demirag, Hatice
    Cin, Aynur
    Hintistan, Sevilay
    JOURNAL OF NURSOLOGY, 2025, 28 (01): : 28 - 37
  • [37] A randomized double-blind comparison of nortriptyline and paroxetine in older depressed patients
    Mulsant, BH
    Pollock, BG
    Nebes, R
    Sweet, RA
    French, C
    Stack, J
    Reynolds, CF
    PSYCHOPHARMACOLOGY BULLETIN, 1997, 33 (03) : 478 - 478
  • [38] Prospective, randomized, single-blind comparison of two preparations for screening flexible sigmoidoscopy
    Bini, EJ
    Rosenberg, J
    Weinshel, EH
    Leung, J
    GASTROINTESTINAL ENDOSCOPY, 1999, 49 (04) : AB195 - AB195
  • [39] Prospective, randomized, single-blind comparison of two preparations for screening flexible sigmoidoscopy
    Bini, EJ
    Unger, JS
    Rieber, JM
    Rosenberg, J
    Trujillo, K
    Weinshel, EH
    GASTROINTESTINAL ENDOSCOPY, 2000, 52 (02) : 218 - 222
  • [40] A DOUBLE-BLIND COMPARISON OF VENLAFAXINE AND FLUOXETINE IN PATIENTS HOSPITALIZED FOR MAJOR DEPRESSION AND MELANCHOLIA
    CLERC, GE
    RUIMY, P
    VERDEAUPAILLES, J
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1994, 9 (03) : 139 - 143